Abstract:OBJECTIVE:To study the clinical effects of endovascular reconstruction versus bypass surgery for TASC II(trans-atlantic inter-society consensus II) C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans.METHODS:One hundred and three patients(119 limbs)accepted bypass surgery or endovascular therapy for TASCII C/D femoropopliteal artery lesion between January 2002 and December 2012 at our institution were retrospectively assessed.All the patients were diagnosed with arteriosclerosis obliterins, and all their Rutherford classifications were from 2 to 5 degrees.Among them there were 71 limbs treated by endovascular reconstruction and the other 48 limbs were treated with bypass surgery.We evaluated the short term clinical effect according to the condition when patients left the hospital, and evaluated the long term clinical effect according to the results of the patients' latest follow-up in 2014. Their clinical data before treatment, complication rates, death rates, hospital stays, short term and long term effects, reoperation rates, 1 to 10 years primary and secondary accumulative patency rates and limb salvage rates were compared.RESULTS:There was no significant difference between the bypass group and the endovascular group on the mean age and ankle brachial index before treatment [(67.1 ± 7.1) years(51 to 80 years) vs. (68.0 ± 9.4) years (49 to 91 years), P=0.561;(0.41 ± 0.23) vs. (0.40 ± 0.26), P=0.928]. There were more TASCII D patients in the bypass group than those in the endovascular group (P<0.001), and the rutherford classification was higher in the endovascular group than that in the bypass group. The difference in the mean follow-up between the bypass group and the endovascular group was not significant [(41.7 ± 23.6) months vs. (59.5 ± 41.6) months, P=0.065]. Five peri-operative complication cases occurred in the bypass group, including 2 cases of acute thrombosis,1 case of infection and 2 cases of heart failure, and only 1 complication case occurred in the endovascular group that was heart failure.The complication rate was higher in the bypass group than that in the endovascular group [10.4% vs. 1.4%, P=0.039]. And there was no death in both the groups.Compared with the endovascular group, the bypass group had a longer hospital stays [(13.2 ± 4.7) d vs.(6.5 ± 3.1) d, P<0.001], a higher reoperation rate (58.3% vs.31.0%,P=0.003), a better short term, obvious, and effective rate (25.0% vs. 9.9%, P=0.027), a worse long term deterioration rate (37.5% vs. 18.3%, P=0.019) and higher 1 to 10 years primary and secondary accumulative patency rates(P=0.001, P=0.001).There was no significant difference between the two groups on the increase of ankle brachial index [(0.34 ± .28) vs. (0.31 ± 0.23), P=0.371], and short term and long term total effective rates (89.6% vs.84.5%, P=0.426; 45.8% vs. 56.3%, P=0.260), and limb salvage rate (83.3% vs.94.4%, P=0.051).CONCLUSION:Endovascular therapy is a safe, effective and minimally invasive therapy for TASCII C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans.

Comparison of the clinical effects of endovascular therapy and bypass surgery for Trans-Atlantic Inter-Society ConsensusⅡC/D femoropopliteal artery disease

[Comparison of the Clinical Efficacy of Endovascular Reconstruction Versus Bypass Surgery for Transatlantic Inter-Society Consensus II C/D Femoropopliteal Artery Lesion Resulted from Arteriosclerosis Obliterans].

The Efficacy Analysis of Endovascular Intervention Therapy for Transatlantic Inter Society Consensus Type C and Type D Femoropopliteal Arteriosclerosis Lesion

Interventional therapy vs arterial bypass surgery for TASC Ⅱ C and D lesions of femoropopliteal arteriosclerosis obliterance

Long Term Results of Endovascular Therapy and Aortofemoral Bypass for Transatlantic Inter-Society Type C and D Aortoiliac Occlusive Disease

Endovascular Interventions for Transatlantic Intersociety Consensus Ii C and D Femoropopliteal Lesions

The clinical efficacy of endovascular intervention for femoropopliteal arteriosclerosis

Endovascular treatment of femoropopliteal atherosclerotic occlusive disease

Analysis to Angioplasty and Bypass Surgery for Occlusive Lnfrapopliteal Artery Disease

Comparison of Clinical Outcomes of Endovascular Therapy and Hybrid Surgery in the Treatment of Trans-Atlantic Inter-Society Consensus II D Aortoiliac Occlusive Disease.

Meta-Analysis of Randomised Controlled Trials Comparing Bypass and Endovascular Revascularisation for Peripheral Artery Disease

[Meta analysis of clinical safety and efficacy evaluation of peripheral arterial disease patients with critical limb ischemia who accepted bypass surgery or endovascular therapy].

The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty

Analysis of results of the below-the-knee endovascular therapy for critical limb ischemia

A comparison between combined open bypass revascularization and free tissue transfer versus endovascular revascularization and free tissue transfer for lower limb preservation

Intravascular interventional therapy combined with convention surgery for treatment of lower extremity multilevel atherosclerotic occlusive disease

An indirect comparison by Bayesian network meta-analysis of drug-coated devices versus saphenous vein graft bypass in femoropopliteal arterial occlusive disease

Outcomes of Endovascular Recanalization Versus Autogenous Venous Bypass for Thromboangiitis Obliterans Patients with Critical Limb Ischemia Due to Tibioperoneal Arterial Occlusion

Mid-Term Outcomes Of Endovascular Treatment And Risk Factors For Recurrence In Patients With Trans-Atlantic-Inter-Society Ii C/D Femoropopliteal Lesions

Endovascular intervention for infrapopliteal arterial occlusion

Endovascular Therapy Based on Angiosome Concept for Critical Lower Limb Ischemia